BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16495269)

  • 1. Inactivation of herpes simplex virus clinical isolates by using a combination microbicide.
    Isaacs CE; Rohan L; Xu W; Jia JH; Mietzner T; Hillier S
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1063-6. PubMed ID: 16495269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipid-peptide microbicide inactivates herpes simplex virus.
    Isaacs CE; Jia JH; Xu W
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3182-4. PubMed ID: 15273146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity of clinical isolates and drug-resistant mutants of herpes simplex virus against seven antiviral drugs.
    Salmerón F; Hernáez R; Rodríguez C
    J Chemother; 1989 Jul; 1(4 Suppl):1110-2. PubMed ID: 16312794
    [No Abstract]   [Full Text] [Related]  

  • 4. Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.
    Isaacs CE; Xu W
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3806-14. PubMed ID: 23716050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir susceptibility of herpes simplex virus isolates at King Chulalongkorn Memorial Hospital, Bangkok.
    Sangdara A; Bhattarakosol P
    J Med Assoc Thai; 2008 Jun; 91(6):908-12. PubMed ID: 18697392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
    Isaacs CE; Wen GY; Xu W; Jia JH; Rohan L; Corbo C; Di Maggio V; Jenkins EC; Hillier S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):962-70. PubMed ID: 18195068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
    Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R
    J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
    Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc salts inactivate clinical isolates of herpes simplex virus in vitro.
    Arens M; Travis S
    J Clin Microbiol; 2000 May; 38(5):1758-62. PubMed ID: 10790094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSV neutralization by the microbicidal candidate C5A.
    de Witte L; Bobardt MD; Chatterji U; van Loenen FB; Verjans GM; Geijtenbeek TB; Gallay PA
    PLoS One; 2011 May; 6(5):e18917. PubMed ID: 21573158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & S. G. Harrison and essential oil, eugenol.
    Tragoolpua Y; Jatisatienr A
    Phytother Res; 2007 Dec; 21(12):1153-8. PubMed ID: 17628885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
    Weinberg A; Leary JJ; Sarisky RT; Levin MJ
    J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isatin-β-thiosemicarbazones as potent herpes simplex virus inhibitors.
    Kang IJ; Wang LW; Hsu TA; Yueh A; Lee CC; Lee YC; Lee CY; Chao YS; Shih SR; Chern JH
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1948-52. PubMed ID: 21356589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2.
    Vilhelmova N; Jacquet R; Quideau S; Stoyanova A; Galabov AS
    Antiviral Res; 2011 Feb; 89(2):174-81. PubMed ID: 21134403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.